Oncotarget

Research Papers:

Cystathionine- γ-lyase promotes process of breast cancer in association with STAT3 signaling pathway

Jing You, Xiaoyan Shi, Huimin Liang, Juan Ye, Lupeng Wang, Huanxiao Han, Hongyu Fang, Wenyi Kang and Tianxiao Wang _

PDF  |  HTML  |  How to cite

Oncotarget. 2017; 8:65677-65686. https://doi.org/10.18632/oncotarget.20057

Metrics: PDF 1606 views  |   HTML 2606 views  |   ?  


Abstract

Jing You1, Xiaoyan Shi1, Huimin Liang2, Juan Ye1, Lupeng Wang1, Huanxiao Han1,Hongyu Fang1, Wenyi Kang1 and Tianxiao Wang1

1College of Pharmacy, Henan University, Kaifeng 475004, Henan Province, China

2Huaihe Hospital, Henan University, Kaifeng 475000, Henan Province, China

Correspondence to:

Tianxiao Wang, email: [email protected]

Keywords: cystathionine-γ-lyase, H2S, transcription factor STAT3, breast cancer, growth

Received: May 25, 2017     Accepted: July 25, 2017     Published: August 07, 2017

ABSTRACT

Here we provide evidences to link cystathionine-γ-lyase (CSE) to the development of breast cancer. CSE expression is up-regulated in both breast cancers and breast cancer cell lines and results in proliferation and migration of breast cancer cells. CSE Function in breast cancer depends on the STAT3 signaling pathway, a regulator of critical cell functions including cell growth in a wide variety of human cancer cells via activating the expression of relative genes. STAT3 positively relates to CSE expression. It activates the CSE promoter via a direct binding to the promoter. Moreover, CSE could reversely regulate STAT3 expression and consequently enhance the effect of STAT3 on CSE. Taken together, these data demonstrate for the first time the roles of CSE in breast cancer leading to breast cancer development in association with STAT3 signaling pathway.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 20057